Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 456906 in Healthy Male Volunteers
Clinical trial NCT03175211 · COMPLETED
Trial details
- NCT number
- NCT03175211
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-30
- Primary completion
- 2018-02-19
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.